Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper
| Autor: | Antonino Romano, Knut Brockow, Cristobalina Mayorga, María José Torres, Gülfem Çelik, Aslı Gelincik, Marina Atanaskovic-Markovic, Annick Barbaud, Ozge Soyer, Inmaculada Doña |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Drug
medicine.medical_specialty SARS‐CoV2 medicine.medical_treatment media_common.quotation_subject Immunology desensitization Review Article Disease medicine.disease_cause Asymptomatic Drug Hypersensitivity 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine COVID‐19 Pandemic medicine Humans Immunology and Allergy drug hypersensitivity reactions Intensive care medicine Pandemics Review Articles Coronavirus Desensitization (medicine) media_common SARS-CoV-2 business.industry Academies and Institutes COVID-19 3. Good health Europe 030228 respiratory system Position paper Differential diagnosis medicine.symptom business |
| Zdroj: | Allergy |
| ISSN: | 1398-9995 0105-4538 |
| Popis: | Coronavirus disease 2019 (COVID‐19), a respiratory tract infection caused by a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2, leads to a wide spectrum of clinical manifestations ranging from asymptomatic cases to patients with mild and severe symptoms, with or without pneumonia. Given the huge influence caused by the overwhelming COVID‐19 pandemic affecting over three million people worldwide, a wide spectrum of drugs is considered for the treatment in the concept of repurposing and off‐label use. There is no knowledge about the diagnosis and clinical management of the drug hypersensitivity reactions that can potentially occur during the disease. This review brings togetherall the published information about the diagnosis and management of drug hypersensitivity reactions due to current and candidate off‐label drugs andhighlights relevant recommendations. Furthermore, it gathers all the dermatologic manifestations reported during the disease for guiding the clinicians to establish a better differential diagnosis of drug hypersensitivity reactionsin the course of the disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text